Fighting the SEC: Father Lemelson’s Decade-Long Battle
When Father Emmanuel Lemelson criticized a pharmaceutical company, the SEC came after him. Ten years later, the fight continues — with questions of jury trials, due process, and agency bias at the center. Mark Chenoweth, John Vecchione, and Russ Ryan unpack the case.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.